Menveo

Menveo Vaccine is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo Vaccine is approved for use in persons aged 2 months through 55 years.

Menveo Vaccine should not be given to patients with known allergy to any other ingredients of this medicine, or any other similar medicines in the past. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. If you have had an allergic reaction to any medicine earlier, inform your doctor about it.

Yes, a single booster dose of Menveo Vaccine may be administered to individuals aged 15 through 55 years who may be at a continued risk of getting meningococcal disease, if at least 4 years have passed since a prior dose of it was given. If you have any doubts, consult your doctor.

Menveo Vaccine is given by a trained healthcare professional or a doctor only and should not be self-administered. Usually, it is given into the muscle of your upper arm, but it may also be given in the thigh muscle in children. Follow your doctor’s instructions carefully to get maximum benefit from Menveo Vaccine.

No. Menveo Vaccine will not cause meningococcal disease. It just helps your body in producing antibodies against it, so that your body can fight the infection if you are exposed to it in future.